BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32871815)

  • 1. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
    Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancer.
    Maezawa Y; Aoyama T; Kano K; Tamagawa H; Numata M; Hara K; Murakawa M; Yamada T; Sato T; Ogata T; Oshima T; Yukawa N; Yoshikawa T; Masuda M; Rino Y
    J Cancer; 2019; 10(22):5527-5535. PubMed ID: 31632496
    [No Abstract]   [Full Text] [Related]  

  • 4. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
    Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
    J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
    Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
    Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
    Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
    Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.
    Takahara N; Nakai Y; Saito K; Sasaki T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Isayama H; Koike K
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1828-1835. PubMed ID: 32267557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer.
    Phillips A; Singh K; Pounds R; Sundar S; Kehoe S; Nevin J; Elattar A; Balega J
    J Obstet Gynaecol; 2017 Nov; 37(8):1070-1075. PubMed ID: 28741395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
    Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
    Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
    Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
    [No Abstract]   [Full Text] [Related]  

  • 12. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.
    Zhou S; Zhang XH; Zhang Y; Gong G; Yang X; Wan WH
    Cancer Manag Res; 2022; 14():1683-1691. PubMed ID: 35573259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of the Age-Adjusted Charlson Comorbidity Index for Outcomes After Hepatic Resection of Hepatocellular Carcinoma.
    Shinkawa H; Tanaka S; Takemura S; Amano R; Kimura K; Nishioka T; Miyazaki T; Kubo S
    World J Surg; 2020 Nov; 44(11):3901-3914. PubMed ID: 32651603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
    Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
    World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
    Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
    J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.
    Tanaka H; Takenaka Y; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Takemoto N; Cho H; Yamamoto M; Yamamoto Y; Inohara H
    Acta Otolaryngol; 2017 Jun; 137(6):668-673. PubMed ID: 28084858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Use Of Age-Adjusted Charlson Comorbidity Index (ACCI) As A Risk Stratification Tool For Development Of Postoperative SARS-COV-2 Infection In Surgical Patients.
    Bhatti KM; Hamzah B; Rehman S; Birkett E; Langford W; Aung M; Canelo R
    J Ayub Med Coll Abbottabad; 2021; 33(4):622-627. PubMed ID: 35124920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy.
    Song J; Lin Y; Zhang J; Liu S; Zhou J; Zeng Q; Lin Z; Fu R; Qiu M; Hu Z
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
    Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
    Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.